Therefore, the results of a previous study by Petrarca et al(18), indicating that survivin may be a predictive biomarker of pCR to NAC in patients with stage II and III breast cancer, were not in accordance with our results and require further investigation. The gene discussed is BIRC5; the disease is breast cancer.